Jan 8, 2026 03:09AM UBS Downgrades Ventyx Biosciences Inc (VTYX) to Neutral

Jan 8, 2026 03:09AM Canaccord Genuity Downgrades Ventyx Biosciences Inc (VTYX) to Hold

Jan 8, 2026 03:08AM Clear Street Downgrades Ventyx Biosciences Inc (VTYX) to Hold

Jan 7, 2026 04:20PM Lilly to acquire Ventyx Biosciences for $1.2 billion in cash

Jan 7, 2026 09:37AM Eli Lilly-Ventyx Deal Could Come Wednesday, Sources Say -- WSJ

Jan 7, 2026 04:56AM Ventyx Biosciences (VTYX) call put ratio 1.6 calls to 1 put into share price up before the bell

Jan 7, 2026 01:04AM UBS Starts Ventyx Biosciences Inc (VTYX) at Buy

Jan 6, 2026 04:42PM After-hours movers: Strategy, Mobileye, Ventyx Bioscience, Praxis

Jan 6, 2026 03:44PM Ventyx Biosciences (VTYX) halted on volatility following WSJ report

Jan 6, 2026 03:41PM Eli Lilly & Co. (LLY) Nears Deal for Ventyx Biosciences (VTYX) - WSJ

Dec 5, 2025 11:17AM Increasing unusual option volume: VTYX IVZ RZLT ULTA NOG BRR PRAX FRSH IRBT

Dec 2, 2025 07:04AM Ventyx adds advisors and delays trial data to Q1 2026

Nov 7, 2025 07:47AM Ventyx Biosciences, Inc. (VTYX) Tops Q3 EPS by 13c

Nov 5, 2025 06:04AM H.C. Wainwright Upgrades Ventyx Biosciences Inc (VTYX) to Buy

Oct 23, 2025 06:50AM H.C. Wainwright Reiterates Neutral Rating on Ventyx Biosciences Inc (VTYX)

Sep 30, 2025 04:32PM Clear Street Starts Ventyx Biosciences Inc (VTYX) at Buy

Aug 7, 2025 04:20PM Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 8c

Jun 23, 2025 07:09AM Canaccord Genuity Reiterates Buy Rating on Ventyx Biosciences Inc (VTYX)

Jun 18, 2025 06:45AM Chemours Company (CC) Updates Q2 Guidance

Jun 18, 2025 06:45AM H.C. Wainwright Reiterates Neutral Rating on Ventyx Biosciences Inc (VTYX)

Jun 17, 2025 07:01AM Ventyx Biosciences (VTYX) Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial of VTX3232

Jun 9, 2025 08:29AM Piper Sandler on Ventyx Biosciences Inc (VTYX): 'We Remain Bullish on Robust NLRP3 Portfolio'

May 8, 2025 04:16PM Ventyx Biosciences, Inc. (VTYX) Tops Q1 EPS by 10c

Apr 1, 2025 07:01AM Ventyx Biosciences (VTYX) Expands SAB with Renowned NLRP3 Experts and Prominent Neurodegenerative and Cardiometabolic Disease Specialists

Feb 18, 2025 08:01AM Ventyx Biosciences (VTYX) Announces Presentation of Data from the Phase 2 Trial of Allosteric TYK2 Inhibitor VTX958 in Crohn’s Disease at ECCO 2025

Jan 14, 2025 08:05AM Ventyx Biosciences (VTYX) Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio

Nov 8, 2024 07:14AM Ventyx Biosciences, Inc. (VTYX) Tops Q3 EPS by 2c

Oct 16, 2024 06:55AM H.C. Wainwright Reiterates Neutral Rating on Ventyx Biosciences Inc (VTYX)

Oct 15, 2024 08:02AM Ventyx Biosciences (VTYX) Presents New 52-Week Results from the Phase 2 Trial of VTX002

Sep 24, 2024 06:50AM H.C. Wainwright Reiterates Neutral Rating on Ventyx Biosciences Inc (VTYX)

Sep 23, 2024 08:00AM Ventyx Biosciences (VTYX) Announces $27M Strategic Investment from Sanofi (SNY)

Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025

Aug 30, 2024 08:00AM Ventyx Biosciences (VTYX) Announces CFO Departure

Aug 9, 2024 07:18AM Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 13c

Jul 29, 2024 08:01AM Ventyx Biosciences (VTYX) Phase 2 Trial of VTX958 in Participants with Moderately to Severely Active Crohn’s Disease Did Not Meet its Primary Endpoint

Jul 29, 2024 07:55AM Ventyx Biosciences (VTYX) Halted, News Pending

Jun 13, 2024 06:38AM H.C. Wainwright Maintains Ventyx Biosciences (VTYX) at Neutral, NT-0796 results have "limited significance"